Feng et al. demonstrated that vapreotide-modified core-shell type nanoparticles which co-encapsulated VEGF targeted siRNA and paclitaxel can be effectively transported into BC cells via samostatin receptors. The gene discussed is VEGFA; the disease is breast cancer.